novo nordisk semaglutide alzheimer trial New Alzheimer's explores if weight-loss ingredient could help fight disease GLP-1s for Alzheimer's: Novo Nordisk

Date & Time: Tuesday, March 10, 2026 at 1:00PM ET Speakers: Scott Honken, PharmD , Chief Commercial Officer, Weight Watchers Jane Lee Choe , Head of Market Access, Weight Watchers Sponsored by: Description: Many employers are effectively paying for weight health twice

at low concentrations, it and its metabolites can interfere with aldosterone biosynthesis in the adrenal cortex and inhibit voltage-dependent Ca 2+ channels to exert antihypertensive effects

Pregnant individuals should consult with their healthcare provider before taking any new supplement, including DetoxiGenic

The treatment benefit on the primary composite endpoint was not evident in patients taking SGLT2 inhibitors at baseline, but there were few events in these patients

Zhao M, Wang Y, Li L, Liu S, Wang C, Yuan Y, et al

Dehydration : Severe kidney infections can lead to dehydration, especially if the patient experiences symptoms such as vomiting and diarrhea